Travere Therapeutics (TVTX) Change in Taxes (2015 - 2017)
Travere Therapeutics' (TVTX) quarterly Change in Taxes came in at -$181000.0 in Q1 2017, up 97.88% on a QoQ basis from -$8.5 million in Q4 2016.
Analysis
Travere Therapeutics (TVTX) Change in Taxes (2015 - 2017) Analysis & Trends
Travere Therapeutics (TVTX) has 3 years of Change in Taxes data on file, last reported at -$181000.0 in Q1 2017.
- Quarterly Change in Taxes changed N/A year-over-year to -$181000.0 in Q1 2017, while the trailing twelve-month figure through Mar 2017 was -$10.2 million (changed N/A YoY) and the FY2019 annual result came in at -$555000.0, up 50.71% from the prior year.
- Change in Taxes improved to -$181000.0 in Q1 2017, from -$8.5 million in the prior quarter.
- In the past five years, Change in Taxes ranged from a high of -$181000.0 in Q1 2017 to a low of -$8.5 million in Q4 2016.
- A 3-year average of -$3.4 million and a median of -$1.5 million in 2015 frame the typical range for Change in Taxes.
- The widest YoY moves for Change in Taxes: up 460.36% in 2016, down 460.36% in 2016.
- Tracing TVTX's Change in Taxes over 3 years: stood at -$1.5 million in 2015, then tumbled by 460.36% to -$8.5 million in 2016, then surged by 97.88% to -$181000.0 in 2017.
- The last three Change in Taxes figures came in at -$181000.0 (Q1 2017), -$8.5 million (Q4 2016), and -$1.5 million (Q4 2015), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | - |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | - |
| 10 | Travere Therapeutics | 6.11 Bn | 6.11 Bn | 162.52 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2017 | -181,000.00 |
| Dec 31, 2016 | -8.52 Mn |
| Dec 31, 2015 | -1.52 Mn |